VivoSeq
Metabolic & Endocrine

Cushing's Disease

0

Pipeline Programs↗

1

Active Trials↗

3

Companies Involved↗

Cushing's Disease is an early-stage landscape with 0 programs across 3 companies. The most active players are Novartis, Corcept Therapeutics, Lundbeck.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

PreclinicalC

Corcept Therapeutics

0 programs

PreclinicalLundbeck logo

Lundbeck

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed3 · 38%
Unknown status2 · 25%
Withdrawn1 · 13%
Recruiting1 · 13%
Terminated1 · 13%

Clinical Trials

Trial Activity

8 trials

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Recruiting·Lundbeck logoLundbeck·Phase 2·NCT06471829·18 enrolled
A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Completed·Novartis logoNovartis·Phase 2·NCT00088608·26 enrolled
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Completed·Novartis logoNovartis·Phase 3·NCT01582061·104 enrolled
Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment
Completed·UUniversity of Palermo·Phase 4·NCT03080181·24 enrolled
Treatment of Cushing's Disease With R-roscovitine
Terminated·SShlomo Melmed, MD·Phase 2·NCT02160730·4 enrolled
Mifepristone in Children With Refractory Cushing's Disease
Withdrawn·CCorcept Therapeutics·Phase 3·NCT01925092
Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
Unknown status·HHuashan Hospital·Phase 2·NCT02484755·6 enrolled
Preoperative Bexarotene Treatment for Cushing's Disease
Unknown status·UUniversity of Virginia·Phase 1/2·NCT00845351·6 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)